Article Text

Download PDFPDF
Rationale, development and implementation of the ReACanROC registry for out-of-hospital cardiac arrests in France and Canada
  1. Matthieu Heidet1,2,3,
  2. Hervé Hubert4,5,
  3. Brian E Grunau6,7,8,9,
  4. Sheldon Cheskes10,11,
  5. Valentine Baert4,5,
  6. Laurie Fraticelli12,13,
  7. Julie Freyssenge12,14,
  8. Eric Lecarpentier1,
  9. Audra Stitt11,
  10. John M Tallon6,9,
  11. Karim Tazarourte14,15,
  12. Courtney Truong11,
  13. Christian Vaillancourt16,17,
  14. Christian Vilhelm5,
  15. Kosma Wysocki11,
  16. Jim Christenson6,7,8,
  17. Carlos El Khoury12,14,18
  18. Gr-ReAC and CanROC investigators
  1. 1 SAMU 94, Hôpitaux universitaires Henri Mondor, Assistance Publique - Hopitaux de Paris (AP-HP), Créteil, France
  2. 2 EA-3956 (Intelligent Control in Networks, CIR), Université Paris-Est Créteil (UPEC), Créteil, France
  3. 3 Emergency department, Hôpitaux universitaires Henri Mondor, Assistance Publique - Hôpitaux de Paris (AP-HP), Créteil, France
  4. 4 ULR 2694 - METRICS : Évaluation des technologies de santé et des pratiques médicales, Université de Lille, Lille, France
  5. 5 French national out-of-hospital cardiac arrest registry - Registre électronique des Arrêts Cardiaques (RéAC), Lille, France
  6. 6 Department of Emergency Medicine, The University of British Columbia, Vancouver, British Columbia, Canada
  7. 7 Emergency Department, St. Paul's Hospital, Vancouver, British Columbia, Canada
  8. 8 Centre for health evaluation and outcomes sciences (CHEOS), Vancouver, British Columbia, Canada
  9. 9 British Columbia Emergency Health Services (BCEHS), Vancouver, British Columbia, Canada
  10. 10 Sunnybrook center for prehospital medicine, Toronto, Ontario, Canada
  11. 11 Applied Health Research Centre, Li Ka Shing Knowledge Institute of St Michaels Hospital, Toronto, Ontario, Canada
  12. 12 RESCUE Network, Hussel Hospital, Vienne, France
  13. 13 EA-4129 (Laboratory Systemic Health Care), University of Lyon 1, Lyon, France
  14. 14 INSERM U1290 (Research on Healthcare Performance, RESHAPE), Université Claude Bernard Lyon 1, Lyon, France
  15. 15 Emergency Department and SAMU69, Hospices Civils de Lyon, Lyon, France
  16. 16 Department of Emergency Medicine, University of Ottawa, Ottawa, Ontario, Canada
  17. 17 Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
  18. 18 Emergency Department, Médipôle, Villeurbanne, France
  1. Correspondence to Dr Matthieu Heidet, SAMU 94, Assistance Publique - Hopitaux de Paris, 94000 Créteil, France; matthieu.heidet{at}


France and Canada prehospital systems and care delivery in out-of-hospital cardiac arrests (OHCAs) show substantial differences. This article aims to describe the rationale, design, implementation and expected research implications of the international, population-based, France-Canada registry for OHCAs, namely ReACanROC, which is built from the merging of two nation-wide, population-based, Utstein-style prospectively implemented registries for OHCAs attended to by emergency medical services. Under the supervision of an international steering committee and research network, the ReACanROC dataset will be used to run in-depth analyses on the differences in organisational, practical and geographic predictors of survival after OHCA between France and Canada. ReACanROC is the first Europe-North America registry ever created to meet this goal. To date, it covers close to 80 million people over the two countries, and includes approximately 200 000 cases over a 10-year period.

  • access to care
  • cardiac care
  • care systems
  • chain of survival
  • cardiac arrest
  • prehospital care

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Handling editor Caroline Leech

  • Correction notice This paper has been updated to amend author name 'Julie Freyssenge'.

  • ReACanROC Collaborators Matthieu Heidet, Brian Grunau, Hervé Hubert,

    Sheldon Cheskes, Valentine Baert, Laurie Fraticelli, Julie Freyssenge, Eric Lecarpentier, François Revaux, Julien Vaux, Charlotte Chollet-Xémard, Nadia Mansouri, Audra Stitt,John Tallon, Karim Tazarourte, Courtney Truong, Christian Vaillancourt, Benajemin Leung, Christian Vilhelm, Kosma Wysocki, Jim Christenson, Carlos El Khoury, Magali Bischoff, Sylvie Besnier, Manya Charrette, Lauren Tierney, Helen Connolly, Sarah Pennington.

  • Contributors All authors have participated in the work, have reviewed, and agree with the content of the article. None of the article contents is under consideration for publication in any other journal or has been published in any journal. No portion of the text has been copied from other material in the literature (unless in quotation marks, with citation). I am aware that it is the author’s responsibility to obtain permission for any figures or tables reproduced from any prior publications, and to cover fully any costs involved. Such permission must be obtained prior to final acceptance.

  • Funding ReAC is funded by the French Society of Emergency Medicine ('Société Française de Médecine d’Urgence', SFMU), the French Federation of Cardiology ('Fédération Française de Cardiologie', FFC), the Mutual of National Education ('Mutuelle de l’Éducation Nationale', MGEN), Lille University, the French northern region ('Hauts-de-France'), and the European community. CanROC is funded by Canadian Institutes of Health Research, and the Heart and Stroke Foundation of Canada.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.